+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030- Product Image
Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030- Product Image
Sale

Dog Vaccines Market by Vaccine Type, Technology, End User, Distribution Channel, Application, Age Group, Dog Size - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6015510
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dog Vaccines Market grew from USD 2.05 billion in 2023 to USD 2.21 billion in 2024. It is expected to continue growing at a CAGR of 8.03%, reaching USD 3.52 billion by 2030.

The scope of the dog vaccines market encompasses products designed to prevent canine diseases such as rabies, distemper, parvovirus, and others. These vaccines are crucial for maintaining pet health, reducing the spread of zoonotic diseases, and ensuring public safety. They are primarily utilized by veterinarians in clinics, commercial pet hospitals, and even by pet owners through home-administered solutions. The necessity of dog vaccines arises from the increasing companionship role pets play globally, which has heightened awareness around pet health and wellbeing. Applications extend to regular veterinary care and preventive healthcare regimes for dogs. The end-use scope spans commercial veterinary practices, households, and animal shelters.

Key growth factors in the market include the rising pet ownership rates worldwide, increasing government initiatives for pet vaccination, and technological advancements leading to more effective vaccine formulations. Additionally, improved access to veterinary care in emerging markets and the growing trend of pet insurance bolster demand. Current opportunities lie in the expansion of distribution networks in developing regions, the introduction of combination vaccines, and personalized vaccines built on bioinformatics and genomic insights. Companies are recommended to invest in research collaborations and partnerships with veterinary institutions to harness these opportunities.

However, market growth faces challenges such as stringent regulatory frameworks, high costs associated with vaccine development, and the need for cold chain logistics to ensure vaccine efficacy. Moreover, occasional vaccine hesitancy among pet owners due to misinformation or adverse reaction concerns can impede growth.

Innovation areas include developing vaccines with extended duration of immunity, alternative delivery methods such as oral vaccines, and comprehensive vaccines covering multiple pathogens. Research into novel adjuvants and preservative-free formulations also presents growth potential. The market is dynamic, with competition primarily driven by advancements in biotechnology and consumer awareness. Companies that focus on R&D, strategic alliances, and consumer education are likely to excel within this evolving landscape.

Understanding Market Dynamics in the Dog Vaccines Market

The Dog Vaccines Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing pet ownership and rising awareness about animal health and vaccinations
    • Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
    • Rising incidences of zoonotic diseases and the role of vaccines in prevention
    • Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
  • Market Restraints
    • Lack of awareness and education among pet owners about the importance of dog vaccination
    • Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
  • Market Opportunities
    • Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
    • Rising investment in research and development for next-generation dog vaccines with fewer side effects
    • Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
  • Market Challenges
    • Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
    • Balancing the rising costs of research, development, and production in the dog vaccine industry

Exploring Porter’s Five Forces for the Dog Vaccines Market

Porter’s Five Forces framework further strengthens the insights of the Dog Vaccines Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Dog Vaccines Market

External macro-environmental factors deeply influence the performance of the Dog Vaccines Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Dog Vaccines Market

The Dog Vaccines Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Dog Vaccines Market

The Dog Vaccines Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Dog Vaccines Market

The Dog Vaccines Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dog Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc., Bayer Animal Health GmbH, Biogenesis Bago, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Chanelle Pharma Group, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, Hipra, IDEXX Laboratories, Inc., Intas Pharmaceuticals Ltd., Kyoritsu Seiyaku Corporation, Merck & Co., Inc., Merial Ltd., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Dog Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Vaccine Type
    • Core Vaccines
      • Canine Adenovirus
      • Canine Distemper Virus
      • Canine Parvovirus
      • Rabies
    • Non-Core Vaccines
      • Bordetella Bronchiseptica
      • Borrelia Burgdorferi
      • Leptospira Canicola
  • Technology
    • DNA Vaccines
    • Inactivated Vaccines
    • Live Attenuated Vaccines
    • Recombinant Vaccines
  • End User
    • Animal Hospitals
    • Pet Clinics
    • Research Institutes
    • Veterinary Clinics
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
    • Vaccination Camps
    • Veterinary Clinics & Hospitals
  • Application
    • Disease Prevention
    • Therapeutic
  • Age Group
    • Adult Dogs
    • Puppies
    • Senior Dogs
  • Dog Size
    • Giant Breed
    • Large Breed
    • Medium Breed
    • Small Breed
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing pet ownership and rising awareness about animal health and vaccinations
5.1.1.2. Government initiatives and regulations supporting mandatory pet vaccinations and animal disease control
5.1.1.3. Rising incidences of zoonotic diseases and the role of vaccines in prevention
5.1.1.4. Advancements in veterinary medicine and increasing investment in pet healthcare infrastructure
5.1.2. Restraints
5.1.2.1. Lack of awareness and education among pet owners about the importance of dog vaccination
5.1.2.2. Stringent regulatory requirements and lengthy approval process for dog vaccines causing delays
5.1.3. Opportunities
5.1.3.1. Advancements in biotechnology leading to development of more effective vaccines for common canine diseases
5.1.3.2. Rising investment in research and development for next-generation dog vaccines with fewer side effects
5.1.3.3. Collaboration between veterinary pharmaceutical companies and research institutions to create innovative vaccine solutions
5.1.4. Challenges
5.1.4.1. Navigating fluctuating regulatory landscapes for approval and distribution of dog vaccines
5.1.4.2. Balancing the rising costs of research, development, and production in the dog vaccine industry
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Dog Vaccines Market, by Vaccine Type
6.1. Introduction
6.2. Core Vaccines
6.2.1. Canine Adenovirus
6.2.2. Canine Distemper Virus
6.2.3. Canine Parvovirus
6.2.4. Rabies
6.3. Non-Core Vaccines
6.3.1. Bordetella Bronchiseptica
6.3.2. Borrelia Burgdorferi
6.3.3. Leptospira Canicola
7. Dog Vaccines Market, by Technology
7.1. Introduction
7.2. DNA Vaccines
7.3. Inactivated Vaccines
7.4. Live Attenuated Vaccines
7.5. Recombinant Vaccines
8. Dog Vaccines Market, by End User
8.1. Introduction
8.2. Animal Hospitals
8.3. Pet Clinics
8.4. Research Institutes
8.5. Veterinary Clinics
9. Dog Vaccines Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies
9.4. Vaccination Camps
9.5. Veterinary Clinics & Hospitals
10. Dog Vaccines Market, by Application
10.1. Introduction
10.2. Disease Prevention
10.3. Therapeutic
11. Dog Vaccines Market, by Age Group
11.1. Introduction
11.2. Adult Dogs
11.3. Puppies
11.4. Senior Dogs
12. Dog Vaccines Market, by Dog Size
12.1. Introduction
12.2. Giant Breed
12.3. Large Breed
12.4. Medium Breed
12.5. Small Breed
13. Americas Dog Vaccines Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Dog Vaccines Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Dog Vaccines Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DOG VACCINES MARKET RESEARCH PROCESS
FIGURE 2. DOG VACCINES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
FIGURE 17. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2030 (%)
FIGURE 19. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 23. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 28. DOG VACCINES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 29. DOG VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DOG VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DOG VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DOG VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DOG VACCINES MARKET DYNAMICS
TABLE 7. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE ADENOVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE DISTEMPER VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DOG VACCINES MARKET SIZE, BY CANINE PARVOVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DOG VACCINES MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DOG VACCINES MARKET SIZE, BY BORDETELLA BRONCHISEPTICA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DOG VACCINES MARKET SIZE, BY BORRELIA BURGDORFERI, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DOG VACCINES MARKET SIZE, BY LEPTOSPIRA CANICOLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DOG VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DOG VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DOG VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DOG VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DOG VACCINES MARKET SIZE, BY ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DOG VACCINES MARKET SIZE, BY PET CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DOG VACCINES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DOG VACCINES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DOG VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DOG VACCINES MARKET SIZE, BY VACCINATION CAMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DOG VACCINES MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DOG VACCINES MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DOG VACCINES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DOG VACCINES MARKET SIZE, BY ADULT DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DOG VACCINES MARKET SIZE, BY PUPPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DOG VACCINES MARKET SIZE, BY SENIOR DOGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DOG VACCINES MARKET SIZE, BY GIANT BREED, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL DOG VACCINES MARKET SIZE, BY LARGE BREED, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL DOG VACCINES MARKET SIZE, BY MEDIUM BREED, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL DOG VACCINES MARKET SIZE, BY SMALL BREED, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 74. CANADA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 75. CANADA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 76. CANADA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 77. CANADA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. CANADA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. CANADA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. CANADA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 82. CANADA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. MEXICO DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MEXICO DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 91. MEXICO DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES DOG VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 121. CHINA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 122. CHINA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 123. CHINA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 124. CHINA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. CHINA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CHINA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. CHINA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. CHINA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 129. CHINA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 130. INDIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 131. INDIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 132. INDIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 133. INDIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. INDIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. INDIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. INDIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. INDIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. INDIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 148. JAPAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 149. JAPAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 150. JAPAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 151. JAPAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 152. JAPAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. JAPAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. JAPAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. JAPAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 156. JAPAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. MALAYSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. PHILIPPINES DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. PHILIPPINES DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. SINGAPORE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. SINGAPORE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 183. SINGAPORE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. SOUTH KOREA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. SOUTH KOREA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. SOUTH KOREA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. TAIWAN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. TAIWAN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 201. TAIWAN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 202. THAILAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 203. THAILAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 204. THAILAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 205. THAILAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. THAILAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. THAILAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. THAILAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. THAILAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 210. THAILAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. VIETNAM DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. VIETNAM DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 219. VIETNAM DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA DOG VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. DENMARK DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 231. DENMARK DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 233. DENMARK DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. DENMARK DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. DENMARK DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. DENMARK DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. DENMARK DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 239. EGYPT DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 241. EGYPT DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 242. EGYPT DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. EGYPT DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. EGYPT DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. EGYPT DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. EGYPT DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 247. EGYPT DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 248. FINLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 249. FINLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 250. FINLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 251. FINLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. FINLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. FINLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. FINLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. FINLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 256. FINLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 258. FRANCE DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 259. FRANCE DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 260. FRANCE DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. FRANCE DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. FRANCE DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. FRANCE DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. FRANCE DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 265. FRANCE DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 266. GERMANY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 267. GERMANY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 268. GERMANY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 269. GERMANY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. GERMANY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. GERMANY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. GERMANY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. GERMANY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 274. GERMANY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. ISRAEL DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 284. ITALY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 285. ITALY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 286. ITALY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 287. ITALY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. ITALY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. ITALY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. ITALY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. ITALY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 292. ITALY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 293. NETHERLANDS DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 294. NETHERLANDS DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 295. NETHERLANDS DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 296. NETHERLANDS DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. NETHERLANDS DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. NETHERLANDS DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 301. NETHERLANDS DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 302. NIGERIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 303. NIGERIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 311. NORWAY DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 312. NORWAY DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 313. NORWAY DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 314. NORWAY DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. NORWAY DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. NORWAY DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. NORWAY DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 318. NORWAY DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 319. NORWAY DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 320. POLAND DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 321. POLAND DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 322. POLAND DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 323. POLAND DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. POLAND DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. POLAND DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. POLAND DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. POLAND DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 328. POLAND DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 329. QATAR DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 330. QATAR DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 331. QATAR DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 332. QATAR DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 333. QATAR DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. QATAR DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. QATAR DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 336. QATAR DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 337. QATAR DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 338. RUSSIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 339. RUSSIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 340. RUSSIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 341. RUSSIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 342. RUSSIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. RUSSIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. RUSSIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 345. RUSSIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 346. RUSSIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 354. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 356. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 357. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 358. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 359. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 360. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 361. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 362. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 363. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 364. SOUTH AFRICA DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 365. SPAIN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 366. SPAIN DOG VACCINES MARKET SIZE, BY CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 367. SPAIN DOG VACCINES MARKET SIZE, BY NON-CORE VACCINES, 2018-2030 (USD MILLION)
TABLE 368. SPAIN DOG VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 369. SPAIN DOG VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 370. SPAIN DOG VACCINES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 371. SPAIN DOG VACCINES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 372. SPAIN DOG VACCINES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 373. SPAIN DOG VACCINES MARKET SIZE, BY DOG SIZE, 2018-2030 (USD MILLION)
TABLE 374. SWEDEN DOG VACCINES MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 375. SWEDEN DOG VACCINES MARKET SIZE, BY C

Companies Mentioned

The leading players in the Dog Vaccines Market, which are profiled in this report, include:
  • Aratana Therapeutics, Inc.
  • Bayer Animal Health GmbH
  • Biogenesis Bago
  • Boehringer Ingelheim Animal Health
  • Ceva Santé Animale
  • Chanelle Pharma Group
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hipra
  • IDEXX Laboratories, Inc.
  • Intas Pharmaceuticals Ltd.
  • Kyoritsu Seiyaku Corporation
  • Merck & Co., Inc.
  • Merial Ltd.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages195
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 2.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.52 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Dog Vaccines Global Market Report 2024 - Product Image

Dog Vaccines Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

Dog Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Companion Animal Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Companion Animal Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 109 Pages
  • Global
From
Veterinary Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Veterinary Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 114 Pages
  • Global
From
Veterinary Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Veterinary Vaccines - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From

About the Market

The Canine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for dogs. Vaccines are used to protect dogs from a variety of diseases, including rabies, distemper, parvovirus, and leptospirosis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal. In addition to vaccines, the Canine Vaccine market also includes products such as flea and tick control, heartworm prevention, and other health-related products. These products are designed to help keep dogs healthy and reduce the risk of disease. Some of the companies in the Canine Vaccine market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Virbac. These companies produce a variety of vaccines and other products for dogs, and are committed to providing quality products to pet owners. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.